VanEck Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $555M | Buy |
|
|||||
|
2025
Q1 | $560M | Buy |
|
|||||
|
2024
Q4 | $565M | Buy |
|
|||||
|
2024
Q3 | $478M | Buy |
|
|||||
|
2024
Q2 | $451M | Buy |
|
|||||
|
2024
Q1 | $439M | Buy |
|
|||||
|
2023
Q4 | $374M | Buy |
|
|||||
|
2023
Q3 | $322M | Buy |
|
|||||
|
2023
Q2 | $273M | Buy |
|
|||||
|
2023
Q1 | $157M | Buy |
|
|||||
|
2022
Q4 | $77.7M | Buy |
|
|||||
|
2022
Q3 | $66.3M | Buy |
|
|||||
|
2022
Q2 | $68.6M | Buy |
|
|||||
|
2022
Q1 | $23.6M | Sell |
|
|||||
|
2021
Q4 | $28.8M | Sell |
|
|||||
|
2021
Q3 | $127M | Sell |
|
|||||
|
2021
Q2 | $190M | Buy |
|
|||||
|
2021
Q1 | $169M | Buy |
|
|||||
|
2020
Q4 | $126M | Sell |
|
|||||
|
2020
Q3 | $124M | Buy |
|
|||||
|
2020
Q2 | $105M | Buy |
|
|||||
|
2020
Q1 | $92.6M | Buy |
|
|||||
|
2019
Q4 | $108M | Buy |
|
|||||
|
2019
Q3 | $39.9M | Buy |
|
|||||
|
2019
Q2 | $38.7M | Buy |
|
|||||
|
2019
Q1 | $37.6M | Sell |
|
|||||
|
2018
Q4 | $41.7M | Sell |
|
|||||
|
2018
Q3 | $64M | Sell |
|
|||||
|
2018
Q2 | $54.5M | Buy |
|
|||||
|
2018
Q1 | $47.5M | Buy |
|
|||||
|
2017
Q4 | $47.1M | Sell |
|
|||||
|
2017
Q3 | $48.6M | Buy |
|
|||||
|
2017
Q2 | $30.2M | Buy |
|
|||||
|
2017
Q1 | $30.7M | Sell |
|
|||||
|
2016
Q4 | $29.8M | Buy |
|
|||||
|
2016
Q3 | $11.6M | Sell |
|
|||||
|
2016
Q2 | $13.2M | Sell |
|
|||||
|
2016
Q1 | $12.9M | Sell |
|
|||||
|
2015
Q4 | $19.6M | Buy |
|
|||||
|
2015
Q3 | $17.4M | Sell |
|
|||||
|
2015
Q2 | $20.8M | Sell |
|
|||||
|
2015
Q1 | $23.4M | Sell |
|
|||||
|
2014
Q4 | $21.2M | Sell |
|
|||||
|
2014
Q3 | $29.5M | Buy |
|
|||||
|
2014
Q2 | $25.3M | Buy |
|
|||||
|
2014
Q1 | $23.1M | Buy |
|
|||||
|
2013
Q4 | $18.5M | Buy |
|
|||||
|
2013
Q3 | $17.3M | Sell |
|
|||||
|
2013
Q2 | $21.6M | Buy |
|